2023
2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut
Gleason-Vergados J, Correa M, Meek J, Banach D. 2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut. Open Forum Infectious Diseases 2023, 10: ofad500.2084. PMCID: PMC10677364, DOI: 10.1093/ofid/ofad500.2084.Peer-Reviewed Original ResearchIncidence rate ratiosIncidence rateCandidemia casesCOVID-19 pandemicNon-white race/ethnicityHospital-onset infectionsEpidemiology of candidemiaRate of candidemiaCOVID-19 treatmentCOVID-19 surgeFuture public health crisesLife-threatening bloodstream infectionsDifferent incidence ratesCOVID-19 case numbersRace/ethnicityCandidemia ratesClinical characteristicsPatient demographicsPublic health crisisInitial surgeMechanical ventilationBloodstream infectionsChi-square analysisCandidemia epidemiologyCandidemia
2011
Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting
Banach DB, Harris TG. Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting. The International Journal Of Tuberculosis And Lung Disease 2011, 15: 1623-1630. PMID: 22118169, DOI: 10.5588/ijtld.11.0017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsAgedAmbulatory Care FacilitiesChildCross-Sectional StudiesFemaleFollow-Up StudiesHumansInterferon-gamma Release TestsLatent TuberculosisLogistic ModelsMaleMiddle AgedMultivariate AnalysisMycobacterium tuberculosisNew York CityPublic HealthRacial GroupsRetrospective StudiesSex FactorsTuberculosisYoung AdultConceptsIndeterminate resultsIndeterminate QFT-G resultsMultivariate logistic regression analysisQFT-G resultsLogistic regression analysisRace/ethnicityChest clinicPatient characteristicsTB GoldClinic settingQuantiFERONFurther studiesPatientsRegression analysisModest proportionHispanicsNew York CityClinicYork City